Santa Rosa med-tech developer TriVascular Inc. said Monday it has raised $60 million in fresh venture capital as it seeks to expand sales of a new medical device in the United States. The company, which has more than 200 employees in Santa Rosa, has now raised more than $200 million in venture funding since its inception 14 years ago. New investor Kaiser Permanente Ventures led the funding round, in partnership with Redmile Group. TriVascular will use the funds to help launch its Ovation Abdominal Stent Graft in the U.S. market.
